auer_r Profile Banner
Rebecca Auer, MD Profile
Rebecca Auer, MD

@auer_r

Followers
791
Following
676
Media
35
Statuses
342

Surgical Oncologist and Scientist, Ottawa Hospital Research Institute

Ottawa, Ontario, Canada
Joined January 2013
Don't wanna be here? Send us removal request.
@auer_r
Rebecca Auer, MD
1 year
Thank you so much TOH/OHRI and uOttawa for the nomination. This is such an honour! ๐Ÿ’•
@OttawaHospital
The Ottawa Hospital
1 year
Congratulations Dr. Rebecca Auer on being recognized as one of 2024 @WXN Canadaโ€™s Most Powerful Women: Top 100 Award Winners! #WXNTop100 This yearโ€™s theme is #BeBold. https://t.co/WdVaBkwgvO
6
7
55
@JAMASurgery
JAMA Surgery
1 year
From @JAMA_current: Among patients undergoing liver resection for a cancer-related indication, tranexamic acid did not reduce bleeding or blood transfusion but increased perioperative complications. https://t.co/mNvn9x8De2
0
12
28
@auer_r
Rebecca Auer, MD
1 year
โ€œOnce you choose hope, anything is possible.โ€ Christopher Reeve. I have repeated that to myself a thousand times. As doctors we always want to improve the outcome, and although sometimes we canโ€™t, we can always affect the journey. Hope is key to every patient journey ๐Ÿ’š
@c3_cholangio
Canadian Cholangiocarcinoma Collaborative ๐Ÿ๐Ÿ’š
1 year
๐ŸŒŸ National Cancer Wellness Awareness Day ๐ŸŒŸ Today, we come together to raise awareness about the importance of #CancerWellness and the incredible support provided by cancer wellness centers and patient groups. Cancer wellness is about nurturing #hope, building strength, and
0
4
32
@c3_cholangio
Canadian Cholangiocarcinoma Collaborative ๐Ÿ๐Ÿ’š
1 year
Had a great meeting last night with 13 advocates discussing ways to mobilize and participate in advocacy for cholangiocarcinoma! These meetings are co-hosted with Cholangio-Hepatocellularcarcinoma Canada + @curecc and happen every 2nd Wednesday of the month. See you July 10!
1
4
8
@c3_cholangio
Canadian Cholangiocarcinoma Collaborative ๐Ÿ๐Ÿ’š
1 year
๐Ÿ’š๐Ÿ’š๐Ÿ’šALBERTA AGREES TO COVER PEMAZYRE FOR CHOLANGIOCARCINOMA ๐Ÿ™Œ๐Ÿค๐Ÿ’ช #CCAHope #cholangiocarcinoma #Alberta #CancerTreatment #HealthcareVictory #AdvocacyWorks https://t.co/xBez2ds1kX
0
6
12
@c3_cholangio
Canadian Cholangiocarcinoma Collaborative ๐Ÿ๐Ÿ’š
1 year
We had our first meeting with @ccranorg about aligning on our common goals! It's amazing to connect with GIANTS in the field of patient-focused cancer care and we are excited to attend their upcoming Biomarkers Conference on June 20-21st! Registration is FREE & open to all
@ccranorg
Colorectal Cancer Resource & Action Network
1 year
Mark your calendars for June 20th and 21st. Register for FREE here: https://t.co/QZSmXi8E1d #CCRAN #BiomarkersConference #CancerCare #CancerCanada #CGP #Biomarkers #PrecisionMedicine
0
1
2
@HalletJulie
Julie Hallet
1 year
๐ŸŽ™๏ธFirst in studio experience today joining @mattgallowaycbc to talk about team diversity in the operating room! with input from @SarooSharda_MD ๐Ÿ“ป๐ŸŽงTune in @TheCurrentCBC to listen Thanks for having me @CBC!
4
6
44
@cancersociety
Canadian Cancer Society
1 year
On May 22 and 23, we gathered experts and people with cancer from across Canada for our Cancer Clinical Trials Forum. They met with politicians to talk about cancer treatment and innovation through clinical trials. Thanks to these committed Members of Parliament for leading this
12
8
16
@c3_cholangio
Canadian Cholangiocarcinoma Collaborative ๐Ÿ๐Ÿ’š
1 year
Noor is one of MANY Canadians that are fighting for equitable access to life saving therapies. @SpencerCTV updated us and @CTVKitchener news story about how Noor's case was brought to the House of Commons by @morricemike. WATCH THE STORY HERE: https://t.co/IAPRmpNoY4 Thank
@c3_cholangio
Canadian Cholangiocarcinoma Collaborative ๐Ÿ๐Ÿ’š
1 year
Without funding, Canadian patients have fallen behind the gold standard of care. Read about Noor's fight - an issue many Canadians with CCA are facing - and sign the petition in the tweet below to stand with her and her family ๐Ÿ’š #CCAHope https://t.co/YTVm7uN2c4
0
11
12
@c3_cholangio
Canadian Cholangiocarcinoma Collaborative ๐Ÿ๐Ÿ’š
1 year
Without funding, Canadian patients have fallen behind the gold standard of care. Read about Noor's fight - an issue many Canadians with CCA are facing - and sign the petition in the tweet below to stand with her and her family ๐Ÿ’š #CCAHope https://t.co/YTVm7uN2c4
Tweet card summary image
ctvnews.ca
A rare cancer treatment could potentially extend the life of an Ontario woman. The problem is, the province wonโ€™t approve the pricey drug.
@c3_cholangio
Canadian Cholangiocarcinoma Collaborative ๐Ÿ๐Ÿ’š
1 year
Make Pemigatinib Drug Available in Ontario and Across Canada - Sign the Petition! https://t.co/b25jAhprad via @CdnChange
0
6
8
@SpencerCTV
Spencer Turcotte
1 year
Ontario woman with incurable cancer pushing province to cover rare cancer drug | CTV News
Tweet card summary image
ctvnews.ca
A rare cancer treatment could potentially extend the life of an Ontario woman. The problem is, the province wonโ€™t approve the pricey drug.
1
2
4
@c3_cholangio
Canadian Cholangiocarcinoma Collaborative ๐Ÿ๐Ÿ’š
1 year
๐Ÿ“ข Today in Parliament: Urgent discussions on ensuring #Pemazyre coverage for patients with FGFR2 fusion-driven cholangiocarcinoma. Access to life-saving treatments shouldn't be a privilegeโ€”it's a right. Let's support equitable healthcare for all! #HealthForAll #CancerTreatment
0
12
19
@cancersociety
Canadian Cancer Society
1 year
On May 22 & 23, we had the pleasure of bringing together the cancer community for our Cancer Clinical Trials Forum in Ottawa.
2
10
28
@ArndtVogel
Arndt Vogel
2 years
Pertuzumab + Trastuzumab in Biliary Tract Cancer With ERBB2/3 Alterations @JCO_ASCO https://t.co/AJEMYgsBCV ๐Ÿ”Ž TAPUR phs 2 ๐Ÿ‘‰DC: 40%; ORR: 32% ๐Ÿ‘‰PFS: 11; mOS 30 weeks ๐ŸงActivity in pts w/ ERBB2/3 amplification, overexpression or mutations @myESMO @EASLnews @ILCAnews @curecc
0
32
68
@ArndtVogel
Arndt Vogel
2 years
2nd line FOLFOX for biliary tract cancers pretreated with cisplatin/gemcitabine @ESMO_Open https://t.co/2E9esLIZWK ๐Ÿ”Žsystematic review & meta-analysis of 6 trials ๐Ÿ‘‰ORR 10%, DCR 50%, mPFS 3mo, mOS 6,5 mo ๐ŸคจHmm, we need to do better... @myESMO @ILCAnews @EASLnews #livertwitter
7
35
91
@ArndtVogel
Arndt Vogel
2 years
Biliary tract cancers: ๐Ÿ‡ซ๐Ÿ‡ท national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT) https://t.co/PJBqVoRbEW ๐Ÿ‘comprehensive recommandations @myESMO @ILCAnews @EASLedu
1
67
161
@GillSharlene
Sharlene Gill, MD, MPH, MBA, FASCO
2 years
Great to see @auer_r sharing progress & opportunities @c3_cholangio #advocacy #curecc ๐Ÿ’š at GI working group @CDNCancerTrials #CCTG2024 ๐Ÿ‡จ๐Ÿ‡ฆ
1
4
40
@BioCanRx
BioCanRx - Canada's Immunotherapy Network
2 years
Great #EarthDay webinar today on greening research labs! Thanks to our speakers Dr. Rebecca Auer @auer_r & Carole Dore of @OttawaHospital & thanks to all who attended! If you missed it - stay tuned - in the coming days we'll post the video online. #Summit4CISpeakerSeries
0
2
8
@auer_r
Rebecca Auer, MD
2 years
What a week! Thank you to so many for your congratulations and kind messages of support. I am honoured to take on this challenging role and privileged to work with amazing colleagues @OttawaHospital and @uOttawaMed!
@OttawaHospital
The Ottawa Hospital
2 years
The Ottawa Hospital is delighted to announce the appointment of Dr. Rebecca Auer as Executive Vice-President of Research and Innovation at The Ottawa Hospital and CEO and Scientific Director of the hospitalโ€™s research institute. https://t.co/OeQmEQarUA
3
1
87
@auer_r
Rebecca Auer, MD
2 years
Thank you for sharing your brave stories Chris and Brenda. โฆโฆ@c3_cholangioโฉ supports you and we urge the other provinces to join Quebec in giving patients access to pemigatinib. Please donโ€™t deny these Canadian patients hope. #CCA #FGF2R
Tweet card summary image
ctvnews.ca
A new dad from the Calgary area is pressing the province to fund a new cancer treatment that might improve his chances of seeing his daughter grow up.
1
11
26